tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Company (TAK)
NYSE:TAK

Compare Takeda Pharmaceutical Company (TAK) vs. Competitors

Compare
1,335 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Takeda Pharmaceutical Company
$14.08
$50.82B
191.70
23.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
Dr Reddy's Laboratories
$13.99
$10.79B
15.81
-12.88%
Viatris
$12.86
$14.81B
-4.15
13.40%
3 Buy
1 Hold
1 Sell
Moderate Buy
Neurocrine
$132.39
$13.20B
31.62
-6.72%
17 Buy
3 Hold
0 Sell
Strong Buy
Teva Pharmaceutical
$31.76
$37.01B
51.87
46.49%
10 Buy
1 Hold
0 Sell
Strong Buy
Haleon PLC Sponsored ADR
$9.52
$43.38B
22.60
6.96%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TAK
Takeda Pharmaceutical Company
16.16
3.51
27.79%
RDY
Dr Reddy's Laboratories
12.92
-1.81
-12.29%
VTRS
Viatris
12.86
2.08
19.29%
NBIX
Neurocrine
132.39
-13.49
-9.25%
TEVA
Teva Pharmaceutical
31.76
9.94
45.55%
HLN
Haleon PLC Sponsored ADR
9.83
0.75
8.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts